The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...

Given data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to applicants and testing site management on ...

In a recent Hayes Management Consulting blog, Leala M. Williams explains if Biometric identification is the answer to patient data integrity issues. Long gone are the days of standalone demographic ...

A new research report from Yale School of Medicine offers an up-close look at how biased artificial intelligence can affect clinical outcomes. The study focuses specifically on the different stages of ...

The Nigerian Economic Summit Group (NESG) has emphasised the importance of addressing data integrity issues as it negatively impacts the nation’s credibility. Without comprehensive reforms, NESG ...